Controlled-release doxazosin in the treatment of benign prostatic hyperplasia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Link
http://www.nature.com/articles/4500820.pdf
Reference25 articles.
1. Chicharro-Molero JA et al. Prevalence of benign prostatic hyperplasia in Spanish men 40 y old or older. J Urol 1998; 159: 878–882.
2. Tsukamoto T et al. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 1995; 154 (Part 1): 391–395.
3. Sagnier P et al. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol 1994; 151: 1266–1270.
4. Berry SJ, Coffey DS, Walsh PC, Ewing LL . The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–479.
5. Caine M, Perlberg S, Meretyk S . A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Br J Urol 1978; 50: 551–554.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preparation and evaluation of the doxazosin-bentonite composite as a pH-dependent controlled-release oral formulation;Applied Clay Science;2022-11
2. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate: in vitro, and in vivo evaluation;Drug Development and Industrial Pharmacy;2019-05-03
3. Preparation and characterization of controlled-release doxazosin mesylate pellets using a simple drug layering-aquacoating technique;Journal of Pharmaceutical Investigation;2013-05-20
4. Efficacy and Safety of the Doxazosin Gastrointestinal Therapeutic System for the Treatment of Benign Prostate Hyperplasia;The Kaohsiung Journal of Medical Sciences;2010-10
5. Extended-Release Doxazosin for Treatment of Renal Transplant Recipients With Benign Prostatic Hyperplasia;Transplantation Proceedings;2009-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3